Institutional Ownership Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). We have compiled data on the 208 institutions that hold shares in the stock, with a total of 80.9 Million shares, which have been reported (via 13F filing form) to have a value of $208 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,565,317
shares
|
$22 Million
0.0% of portfolio
|
Q2 2024
Added 17.13%
|
|
Beryl Capital Management LLC
Redondo Beach, CA |
Feb 14, 2025 Q4 2024 |
5,935,009
shares
|
$15.3 Million
9.37% of portfolio
|
Q4 2024
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
5,625,091
shares
|
$14.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.89%
|
|
Oddo Bhf Asset Management Sas
Paris, I0 |
Feb 12, 2025 Q4 2024 |
5,100,000
shares
|
$13.1 Million
0.78% of portfolio
|
Q4 2024
Added 603.45%
|
|
Fil LTD
Hamilton, D0 |
Feb 13, 2025 Q4 2024 |
4,196,095
shares
|
$10.8 Million
0.01% of portfolio
|
Q4 2024
Added 0.08%
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
3,497,112
shares
|
$8.99 Million
0.0% of portfolio
|
Q4 2024
Added 7.26%
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
3,164,943
shares
|
$8.13 Million
0.01% of portfolio
|
Q4 2024
Added 37.03%
|
|
Magnetar Financial LLC
Evanston, IL |
Feb 11, 2025 Q4 2024 |
2,556,345
shares
|
$6.57 Million
0.21% of portfolio
|
Q4 2024
Added 2.25%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,439,140
shares
|
$6.27 Million
0.0% of portfolio
|
Q4 2024
Added 0.21%
|
|
Alpine Associates Management Inc.
Englewood Cliffs, NJ |
Feb 07, 2025 Q4 2024 |
2,349,966
shares
|
$6.04 Million
0.37% of portfolio
|
Q4 2024
Reduced 43.55%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,297,582
shares
|
$5.9 Million
0.0% of portfolio
|
Q4 2024
Added 0.35%
|
|
Glazer Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,950,000
shares
|
$5.01 Million
0.4% of portfolio
|
Q4 2024
New holding
|
|
Newtyn Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,810,000
shares
|
$4.65 Million
0.95% of portfolio
|
Q4 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,653,689
shares
|
$4.25 Million
0.01% of portfolio
|
Q4 2024
Added 57.49%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,551,372
shares
|
$3.99 Million
0.0% of portfolio
|
Q4 2024
Added 949.57%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,483,040
shares
|
$3.81 Million
0.0% of portfolio
|
Q4 2024
Added 134.45%
|
|
Aqr Arbitrage LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,413,103
shares
|
$3.63 Million
0.19% of portfolio
|
Q3 2024
New holding
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,367,343
shares
|
$3.51 Million
0.0% of portfolio
|
Q4 2024
Reduced 29.23%
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
1,328,525
shares
|
$3.41 Million
0.0% of portfolio
|
Q4 2024
Reduced 29.75%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,298,822
shares
|
$3.34 Million
0.0% of portfolio
|
Q4 2024
Added 867.96%
|
|
Gabelli Funds LLC
Rye, NY |
Feb 13, 2025 Q4 2024 |
1,262,487
shares
|
$3.24 Million
0.03% of portfolio
|
Q4 2024
Added 15.7%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,161,382
shares
|
$2.98 Million
0.0% of portfolio
|
Q4 2024
Reduced 75.73%
|
|
Gabelli & CO Investment Advisers, Inc.
Rye, NY |
Feb 13, 2025 Q4 2024 |
1,058,500
shares
|
$2.72 Million
0.53% of portfolio
|
Q4 2024
Added 26.04%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
991,043
shares
|
$2.55 Million
0.0% of portfolio
|
Q4 2024
Added 2.72%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
893,686
shares
|
$2.3 Million
0.0% of portfolio
|
Q4 2024
Added 3.06%
|